Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Falling Comet
170.9500 3.58 (2.14%)
NSE Sep 02, 2025 15:53 PM
Volume: 1.2M
 

170.95
2.14%

Marksans Pharma

Centrum Broking
Source: Bloomberg, Centrum Research, *as on 17h November 2017 Recommendation and key risks: We have revised our FY18E and FY19E EPS downwards by 14% and 7% respectively in view of forex losses and increase in crude based raw material prices. We downgrade MPL to Hold from Buy rating, with a TP of Rs45 based on 18x March'19 EPS of Rs2.5, and a 10.7% upside from CMP. Key positive upsides would be additional ANDA approvals from US FDA and key...
Marksans Pharma Ltd. has lost -28.63% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended